Drug-Induced Lung Injury
This book covers various aspects of a respiratory system disorder associated with prescribed drugs that do not yet have established treatment guidelines, and for which the only treatment is to discontinue taking the drug. Very little clinical evidence regarding the disorder is available, since randomized trials cannot to be carried out, the onset of the disorder cannot be predicted, and the resulting pathological condition is life-threatening. However, the need for an established treatment continues to grow due to the introduction of many new drugs, such as anti-neoplastic drugs, biological products, and molecular target drugs, the adverse effects of which are difficult to differentiate from those of other lung diseases, such as lung infectious diseases.
Drug-Induced Lung Injury offers a highly beneficial resource not only for respiratory physicians but also all medical clinicians who prescribe drugs, nurses, pharmacists and pharmaceutical scientists. Written by pioneering experts in the field, the book examines a wealth of cases and the insights they yield concerning the diagnosis, treatment and specific drugs causing the disease. It not only fosters a deeper understanding of the disorder but also highlights the current challenges and paves the way for future clinical research.
ERS Handbook of Respiratory Medicine, 3rd Edition
ERS Handbook of Respiratory Medicine, 3rd Edition
The European Respiratory Society (ERS) Handbook of Respiratory Medicine, now in its third edition, is a concise, compact and
easy-to-read guide to each of the key areas in respiratory medicine. Its 20 sections, written by clinicians and researchers at the forefront of the field, explain the structure and function of the respiratory system, its disorders and how to treat them.
The Handbook is a must-have for anyone who intends to remain up to date in the field, and to have within arm’s reach a reference that covers everything from the basics to the latest developments in respiratory medicine.
This book presents original articles that report on new approaches and developments involving pulmonary disorders. Pulmonary health attracts public concern as lungs are the first line of defense of the organism against various contagions and are directly influenced by all too often unhealthy constituents of ambient air, which make them vulnerable to diseases. The articles deal with the pathogenic background and most relevant practical aspects of the widespread pulmonary disorders. Topics include the mechanisms and treatment options of sleep apnea syndrome, occupational exposure to carbon dioxide, and the research on prognostic factors in lung cancer. Another theme tackles quality of life in chronic pathologies and the psychosocial factors, often underestimated, having influence on lung function already in adolescence, and thus liable to shape adult pulmonary morbidity. Reports on the course of recent influenza outbreaks and a rather dismal state of anti-influenza measures top off the content. The volume is addressed to clinicians and researchers, pulmonary doctors, and other professionals engaged in patient care and therapy.
This book discusses a wide range of investigations and practice-oriented advances in pulmonary medicine and critical care.
Pulmonary diseases are a major cause of hospitalization and mortality, affecting millions of people worldwide. Addressing a range of topics, including chronic obstructive pulmonary disease, sleep apnea, and lung cancer, the book offers insights into the disease mechanisms and risk factors, along with practical aspects concerning the maintenance of quality of life, adherence to therapy, and palliative treatment and care. Further, it explores diagnostic and treatment approaches to respiratory dysfunction and respiratory failure, highlighting the beneficial effects of good sleep quality in chronic pulmonary conditions and lung transplant patients. The book also presents novel experimental research on the cellular voltage-gated sodium channels in the mechanism of pathological cough, which is particularly relevant for future targeted antitussive therapy. Lastly, it addresses the epidemiological aspects of pulmonary infections.
As such, this book is a valuable resource for medical scholars, clinicians, family physicians, and other professionals seeking to improve the management of respiratory diseases.
This book contains approximately 120 detailed schematic diagrams that detail disease progression, diagnosis, and treatment; clinical photographic material that illustrates visual diagnostic cues; and figures and flow diagrams that present a concise review of the epidemiology, diagnosis, and management of the disease. The authors cover the drugs recommended for treatment, their mode of action, potential side effects, and recommended uses. They discuss the management of both stable COPD and exacerbations of COPD, differential diagnoses and asthma, management in general practice and in hospitals, and future trends in therapy, such as new bronchodilators and anti-inflammatory treatments.
This book considers chronic obstructive pulmonary disease (COPD) not as a simple inflammation of the lung but as a systemic inflammatory disease. Beginning with epidemiological studies, etiology, diagnosis and treatment, it elaborates further, illustrating some comorbidities and associations with other respiratory diseases. As such it provides numerous improved and more comprehensive treatment methods, including drug therapies as well as some non-drug therapies. There are also chapters describing the pathogenesis, genetic abnormalities and newly discovered pathogenetic mechanisms that are expected to be studied further in the future.
Edited and written by pioneering researchers, each chapter summarizes the latest trends, describes future prospects and explores the unresolved and critical questions. Chronic Obstructive Pulmonary Disease – A Systemic Inflammatory Disease is a valuable resource to beginning researchers, physicians engaged in clinical practice, supervisors, and basic researchers whose work includes COPD.
Chronic obstructive pulmonary disease (COPD) is an all too too common lung condition – usually caused by cigarette smoking – which varies markedly in severity between individuals, and includes conditions previously known as chronic bronchitis and emphysema. It causes progressive symptoms such as breathlessness, wheezing, coughing, reduced exercise tolerance and frequent chest infections.
COPD: The Facts is written for patients with COPD and their families, but it will also be of interest to health professionals. The book describes in detail how a diagnosis is made and what treatments patients are likely to receive. It discusses modern approaches to the management of COPD (both with and without drugs) and includes examples of real-life patient experiences throughout the text, answers to the most frequently asked questions, and advice on how to give up smoking.
At the present time, 430 drugs are known to cause respiratory injury. This represents an increase of almost 200 in the last ten years, and the number is still increasing. This comprehensive, definitive reference work, with an outstanding range of international expert contributors and two of the world’s leading editors, provides an essential referen
This book describes the underlying genetic basis of common pulmonary diseases and discusses their pathogenesis and pathophysiology. These insights provide the basis for understanding different subtypes and phonotypes, and will promote better treatment strategies and individualized medicine. The book provides new and valuable information for the development of the areas of study, as well as practical guidelines for clinicians engaged in treating pulmonary diseases.
This volume of the Respiratory Disease Series – Diagnostic Tools and Disease Managements will broaden the understanding of beginning and experienced researchers and clinicians who treat pulmonary diseases. Moreover, residents and clinicians engaged in medical oncology will find it a valuable guide to support them in their day-to-day work.
This book provides valuable data on the outbreak, aggravation, treatment and prevention of respiratory diseases based on prior experiences of natural disasters such as earthquakes and tsunamis. Poor hygiene and air pollution can lead to the onset of pneumonia and other respiratory disease, while a lack of medical supplies aggravates existing pulmonary diseases such as chronic obstructive pulmonary disease and asthma. Furthermore, there are cases where those forced to live in cramped conditions, such as cars, following a disaster have developed pulmonary thromboembolism as a result of deep vein thrombosis. The large numbers of patients diagnosed with respiratory diseases make understanding the links between natural disasters and pulmonary disease vital.
Disaster and Respiratory Diseases is a valuable resource for all medical staff, including physicians involved in primary care, respiratory medicine and infection control and emergency medicine, as well as respiratory surgeons. It is also useful to national and regional governments concerned about anti-disaster measures.